Featured Content
The Center for Life Science Ventures was founded in 2008 as a startup incubator to help develop young Cornell life science companies. The Center is funded through the Office of the Vice President for Research and Innovation, the Institute of Biotechnology and NYSTAR.
The Center’s program focuses on accelerating research and development of its client’s companies’ technology and products, validating its client companies’ business plans, and strengthening their management teams. The Center’s goal is to facilitate the forward progress of client companies to the point where each will merit significant outside investment, and achieve self-sufficiency. In doing so, the Center for Life Science Ventures contributes to the University’s mission as New York State’s Morrill Land Grant institution to support local, regional, and state-wide Life Sciences jobs/economic development.
News
New biodegradable graft could help cardiovascular patients
1738195200
By Susan Kelley, Cornell Chronicle January 21, 2025 Cornell engineers are aiming to create a big leap in vascular grafts, used to combat cardiovascular disease, the leading cause of death worldwide. The biodegradable graft looks like …
Center Graduate Kanvas Biosciences Secures Additional $12.5M to Advance Its Novel, Microbiome-Based Immuno-oncology Drug Candidates to IND Filing
1720483200
https://www.prnewswire.com/news-releases/kanvas-biosciences-secures-additional-12-5m-to-advance-its-novel-microbiome-based-immuno-oncology-drug-candidates-to-ind-filing-302184016.html With $29.5 million in total funding, the company has developed the world’s leading spatial biology platform, designed for breakthroughs in drug development, clinical diagnostics, agriculture, and food safety. This proprietary mapping technology will first be used …
Startup aiming to reduce plastic reliance joins Cornell incubator
1717977600
By Blaine Friedlander, Cornell Chronicle A company that originated in Syracuse and is aiming to use agricultural waste to replace the petroleum-based plastic liners in coffee cups, takeout containers and other consumer products has joined Cornell’s Center …
Center Graduate Kanvas Biosciences Announces $12 Million Pre-Series A to Accelerate Microbiome Drug Development
1687478400
https://www.prnewswire.com/news-releases/kanvas-biosciences-announces-12-million-pre-series-a-to-accelerate-microbiome-drug-development-301857507.html?tc=eml_cleartime R&D breakthrough for microbiome-associated therapies: Technology brings breakthrough resolution and context to host-microbiome interactions PRINCETON, N.J., June 22, 2023 /PRNewswire/ — Kanvas Biosciences, the leader in microbiome mapping technology, announced today a $12M Pre-Series A funding round. The …